Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Cappelletti

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Tumori|June 30, 1983
Hormone treatment and sex steroid receptors in metastatic renal cell carcinoma: report of a multicentric prospective studyG Pizzocaro, G Di Fronzo, V Cappelletti, et al.
The International Journal of Biological Markers|July 19, 2006
Questioning the utility of pooling samples in microarray experiments with cell linesL Lusa, V Cappelletti, M Gariboldi, et al.
European Urology|January 1, 1983
Adjunctive medroxyprogesterone acetate to radical nephrectomy in category M0 renal cell carcinoma. Preliminary report of a prospective randomized trialG Pizzocaro, G Di Fronzo, L Piva, et al.
ESMO Open|March 9, 2024
Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysisG Nader-Marta, M Monteforte, E Agostinetto, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2022
Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNAE La Rocca, M C De Santis, M Silvestri, et al.
Expert Review of Clinical Pharmacology|January 21, 2021
Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trialA Mennitto, E Verzoni, F Cognetti, et al.
Journal of Cancer Research and Clinical Oncology|January 17, 2022
Mammographic density to predict response to neoadjuvant systemic breast cancer therapyS Di Cosimo, C Depretto, R Miceli, et al.
ESMO Open|March 20, 2021
Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapyE Ortolan, V Appierto, M Silvestri, et al.
ESMO Open|July 2, 2023
A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancerC Chiodoni, S Sangaletti, M Lecchi, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Tumori|June 30, 1983
Hormone treatment and sex steroid receptors in metastatic renal cell carcinoma: report of a multicentric prospective studyG Pizzocaro, G Di Fronzo, V Cappelletti, et al.
The International Journal of Biological Markers|July 19, 2006
Questioning the utility of pooling samples in microarray experiments with cell linesL Lusa, V Cappelletti, M Gariboldi, et al.
European Urology|January 1, 1983
Adjunctive medroxyprogesterone acetate to radical nephrectomy in category M0 renal cell carcinoma. Preliminary report of a prospective randomized trialG Pizzocaro, G Di Fronzo, L Piva, et al.
ESMO Open|March 9, 2024
Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysisG Nader-Marta, M Monteforte, E Agostinetto, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2022
Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNAE La Rocca, M C De Santis, M Silvestri, et al.
Expert Review of Clinical Pharmacology|January 21, 2021
Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trialA Mennitto, E Verzoni, F Cognetti, et al.
Journal of Cancer Research and Clinical Oncology|January 17, 2022
Mammographic density to predict response to neoadjuvant systemic breast cancer therapyS Di Cosimo, C Depretto, R Miceli, et al.
ESMO Open|March 20, 2021
Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapyE Ortolan, V Appierto, M Silvestri, et al.
ESMO Open|July 2, 2023
A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancerC Chiodoni, S Sangaletti, M Lecchi, et al.
Pageof 6